274 A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF TAS-303 IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE
Main Authors: | S Takahashi, K Kato, O Yokoyama, M Takei, M Gotoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Continence |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772973722006294 |
Similar Items
-
THE IMPACT OF PATIENT CHARACTERISTICS ON THE EFFICACY OF TAS-303 FOR STRESS URINARY INCONTINENCE: SUB-GROUP ANALYSES OF A PHASE 2 STUDY
by: O Yokoyama, et al.
Published: (2023-09-01) -
Female urinary incontinence and sexuality
by: Renato Lains Mota -
Utilization of the female urinary incontinence sling in treating male acquired urinary incontinence
by: Rui Xu, et al.
Published: (2023-09-01) -
Prevalence of Anal Incontinence and Constipation in Female Patients with Urinary Incontinence
by: Musa Saraçoğlu, et al.
Published: (2018-04-01) -
Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.
by: Low, B, et al.
Published: (2008)